Ortizo, Baby Girl .

HRN: 23-96-12  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/31/2023
11/07/2023
IVT
44mg
Q24
PSNB
Waiting Final Action 
10/31/2023
AMPICILLIN 250MG (VIAL)
10/31/2023
11/07/2023
IVT
145mg
Q12
PSNB
Waiting Final Action 
10/31/2023
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
10/31/2023
11/07/2023
OU
1 Gram
Once
Eye Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: